BioStock: BiBBInstruments comments on upcoming patent approval

Swedish medtech BiBBInstruments is developing the world’s first CE-marked endoscopic ultrasound-guided core needle biopsy device – EndoDrill. 2023 gets off to a good start for the company with the announcement of an Intention to Grant received from the European Patent Office for its device. BioStock reached out to CEO Fredrik Lindblad for a comment.

Read the article at biostock.se:

https://www.biostock.se/en/2023/01/bibbinstruments-comments-on-upcoming-patent-approval/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/